School Of Medicine Basic Sciences

As Vanderbilt prepares for Giving Day, the Roger Chalkley, Ph.D. Critical Need Fund highlights the powerful impact that philanthropic support can have on trainees navigating the unpredictable realities of life during graduate school. Read More

Joyonna Gamble-George, PhD’16, believes that science is humanitarianism. Thanks to her upbringing and her Vanderbilt training, through the roles she has had—from entrepreneur to research scientist to policy fellow—she has focused on helping people in her personal and professional lives. Read More

Department of Cell and Developmental Biology faculty are unraveling the mysteries of human cells one discovery at a time. Read More

Meet Lisa Evans, senior program assistant in the Department of Biochemistry. Read More

Prashant Donthamsetti, assistant professor of pharmacology at the School of Medicine Basic Sciences, will deliver an upcoming Kairos Lecture on Thursday, March 26. Read More

A new study from the laboratory of Cody Siciliano suggests that two widely used medications for alcohol use disorder—naltrexone and nalmefene—may be equally effective overall but individuals only respond to one of the two medications. The findings could help explain why clinical trials of naltrexone and nalmefene have produced conflicting results and may point toward a precision-medicine strategy for treating alcohol use disorder. Read More

Dr. Teru Nakagawa delivered the inaugural Kairos Lecture. Read More

Researchers identified a small molecule that improves the localization of a potassium channel frequently mislocalized and impaired in the genetic heart rhythm disorder known as long QT syndrome. The study provides proof of principle that future therapies aimed at correcting the underlying molecular defect in this potentially fatal genetic disorder could be viable. Read More

Two new compounds developed at the Vanderbilt University Warren Center for Neuroscience Drug Discovery will enable research into a protein family with ties to Alzheimer’s disease, setting the stage for the development of a different kind of therapeutic than is currently available. Read More

Katrin Karbstein, the co-leader of the Cancer Cell Biology Research Program in the Vanderbilt-Ingram Cancer Center, will now expand her focus to support her department’s mission across research, service, and education, with a special focus on faculty affairs. Read More